Skip to main content
OpenTrials
Completed

NCT Number: NCT01536470

Intraoperative Noradrenaline to Control Arterial Pressure (INPRESS Study)

The purpose of this study is to evaluate whether a preventive strategy of intraoperative arterial hypotension using noradrenaline can reduce the incidence of postoperative organ failure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

About this study

The maintenance of arterial blood pressure is essential for organ perfusion pressure. Intraoperative hypotension is a frequent complication both after induction and during maintenance of anaesthesia, ranging from 5% to 75% depending on the chosen definition. Tissue hypoperfusion exposes to the occurrence of a systemic inflammatory response syndrome and is a key determinant of postoperative complications. Persistent intraoperative hypotension has been reported as an important prognostic factor of postoperative morbidity and mortality. Adequate treatment of arterial hypotension is therefore of particular importance during surgery, but optimal strategy of intraoperative blood pressure management remains undetermined, especially in high-risk patients. Target ranges for arterial pressure are not clearly defined, and hypotension is usually defined as a systolic pressure of less than 80 mmHg or a decrease of more than 40% from baseline.

Traditionally, management of intraoperative hypotension consisted primarily of fluid administration whereas vasoconstrictors, such as Ephedrine chlorhydrate, are often used as a second line therapy. This may, however, expose patients to prolonged hypotension and to excessive fluid administration, and each of them may alter tissue oxygenation.

Recent experimental data have shown that noradrenaline, which has - and -adrenergic effects, has no detrimental effects on microcirculatory blood flow and tissue oxygenation in the intestinal tract. Because of anaesthesia-induced vasodilatation, the use of a continuous infusion of noradrenaline to increase systemic vascular resistance could be useful to prevent detrimental effects of compromised tissue perfusion, especially in high-risk surgical patients.

The primary objective of the study is to compare two strategies of intraoperative blood pressure management in high-risk surgical patients: 1- Continuous infusion of noradrenaline to maintain arterial blood pressure of no more than 10% below its baseline value; 2- Conventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline) using intravenous bolus of Ephedrine chorhydrate.

The investigators hypothesis is that maintenance of arterial blood pressure with noradrenaline could reduce postoperative organ dysfunction in high-risk surgical patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 50 years
  • ASA score ≥ 2
  • Planned and unplanned surgical procedures
  • Abdominal, orthopaedic and vascular surgery
  • Expected duration ≥ 2 hours
  • AKI risk index ≥ class 3

Exclusion criteria

  • Severe preoperative hypertension (not controlled)
  • Creatinine clearance < 30 ml/min or preoperative dialysis
  • Acute cardiac failure
  • Preoperative sepsis
  • Preoperative hemodynamic failure (shock)
  • Intraoperative use of locoregional anaesthesia (epidural and spinal)
  • Patient refusal
  • Pregnancy and/or lactation

Treatment and study plan

noradrenaline

Other

The primary objective of the study is to compare two strategies of intraoperative blood pressure management in high-risk surgical patients: 1- Continuous infusion of noradrenaline to maintain arterial blood pressure of no more than 10% below its baseline value; 2- Conventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline) using intravenous bolus of Ephedrine chorhydrate.

Ephedryne chorydrate

Other

Primary outcomes

  1. Composite endpoint of postoperative SIRS and at least one major organ dysfunction

    Time frame: day-7

Secondary outcomes

  1. Incidence of intraoperative hypotension

    Time frame: at day 7

  2. Incidence of intraoperative hypertension

    Time frame: at day 7

  3. Incidence of intraoperative bradycardia

    Time frame: at day 7

  4. Intraoperative volume of fluid perfused

    Time frame: at day 7

  5. Intraoperative blood losses

    Time frame: at day 7

  6. Need for intraoperative transfusion

    Time frame: at day 7

  7. Postoperative organ failure

    Time frame: at day 7

  8. Biologic criteria: plasma concentration of NGAL, creatinine, CRP, serum lactate, troponine)

    Time frame: at day 7

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Collaborators

  • Aguettant laboratory

Registry information

Official study title

Effectiveness of Noradrenaline to Control Intraoperative Arterial Pressure in High-risk Surgical Patients: A Multicentre Prospective Randomized Controlled Trial

Acronym: INPRESS

Important dates

Study start
2012
Primary completion
2016
Study completion
2016
First posted
Feb 22, 2012
Registry last updated
Oct 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.